生物
细胞凋亡
肺癌
癌症研究
程序性细胞死亡
细胞
细胞生物学
小细胞肺癌
小分子
癌症
肺
癌细胞
信号转导
细胞存活
细胞生长
作者
Jun W. Kim,Christina M. Bebber,Yuqin Dai,Sarah Bopp,Anna Edenhofer,Albert Mao Li,Thomas Rösner,Lena Berning,Ming Hui Yang,Logan B. Leak,Jenny Stroh,Bindesh Shrestha,Ali Taleb Abdallah,Dimitrios Prymidis,Hernando J. Olivos,Maya Baron,Thuyen N. Nguyen,Yan Ting Shue,Yoko Nishiga,Alexandros P. Drainas
出处
期刊:Cell
[Cell Press]
日期:2026-10-01
标识
DOI:10.1016/j.cell.2026.09.045
摘要
Cellular heterogeneity and plasticity are hallmarks of cancer that contribute to tumor growth and therapy resistance. Here, we investigated metabolic heterogeneity in small cell lung cancer (SCLC), an aggressive cancer type with considerable plasticity between neuroendocrine (NE) and non-NE cellular states. Through integrated transcriptomic and metabolomic analyses, we identified a universal dependency on exogenous cysteine/cystine (Cys) across all NE/non-NE SCLC cell states. Notably, NE and non-NE cells with low ASCL1 transcription factor levels underwent ferroptosis upon Cys depletion, whereas ASCL1 high cells underwent apoptosis while remaining resistant to ferroptosis. This ferroptosis resistance was driven by the direct transcriptional activation of GCH1 by ASCL1, resulting in increased levels of the antioxidants BH4/BH2. Accordingly, combined Cys depletion and inhibition of BH4/BH2 synthesis reduced tumor growth in patient-derived xenografts. These findings demonstrate that metabolic state influences cell-death susceptibility in SCLC and provide a rationale for therapeutic strategies that exploit these metabolic differences.
科研通智能强力驱动
Strongly Powered by AbleSci AI